title: Amsacrine retains a special role supporting Food and Drug Administration approval.
authors.forename: Z A
authors.initials: ZA
authors.lastname: Arlin
authors.forename: E J
authors.initials: EJ
authors.lastname: Feldman
authors.forename: P
authors.initials: P
authors.lastname: Cook
authors.forename: T
authors.initials: T
authors.lastname: Ahmed
authors.forename: A
authors.initials: A
authors.lastname: Mittelman
authors.forename: H G
authors.initials: HG
authors.lastname: Chun
authors.forename: C
authors.initials: C
authors.lastname: Puccio
authors.forename: L
authors.initials: L
authors.lastname: Helson
mesh_terms: D000677:Amsacrine / Q000627:therapeutic use*; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000677:Amsacrine